Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
12:21pm, Tuesday, 02'nd Apr 2024
Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.
Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall
07:18pm, Wednesday, 21'st Feb 2024
ALPHARETTA, Ga. , Feb. 21, 2024 /PRNewswire/ -- In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS)
Avanos (AVNS) Q4 Earnings Lag Estimates, Margins Contract
10:40am, Wednesday, 21'st Feb 2024
Despite strength in Avanos' (AVNS) Digestive Health segment, its overall fourth-quarter results reflect soft performances.
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results
07:00am, Tuesday, 20'th Feb 2024
ALPHARETTA, Ga. , Feb. 20, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results.
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
08:41pm, Tuesday, 13'th Feb 2024
ALPHARETTA, Ga. , Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full
LOS ANGELES, CA / ACCESSWIRE / February 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medica
LOS ANGELES, CA / ACCESSWIRE / January 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical
NEW YORK, NY / ACCESSWIRE / January 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, I
LOS ANGELES, CA / ACCESSWIRE / January 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical
New Strong Sell Stocks for January 16th
08:17am, Tuesday, 16'th Jan 2024
AMFPF, ADI and AVNS have been added to the Zacks Rank #5 (Strong Sell) List on January 16, 2024.
LOS ANGELES, CA / ACCESSWIRE / January 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical
LOS ANGELES, CA / ACCESSWIRE / January 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical
New Strong Sell Stocks for January 12th
07:31am, Friday, 12'th Jan 2024
AIR, AVNS and BP have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2024.
New Strong Sell Stocks for January 9th
07:31am, Tuesday, 09'th Jan 2024
AIR, AMSF and AVNS have been added to the Zacks Rank #5 (Strong Sell) List on January 9, 2024.
Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
10:53am, Tuesday, 02'nd Jan 2024
ALPHARETTA, Ga. , Jan. 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42nd Annual J.P.
